BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30003817)

  • 1. The epigenetic modification during the induction of Foxp3 with sodium butyrate.
    Cao T; Zhang X; Chen D; Zhang P; Li Q; Muhammad A
    Immunopharmacol Immunotoxicol; 2018 Aug; 40(4):309-318. PubMed ID: 30003817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of FOXP3-EZH2 Interaction Represents a Pathobiological Mechanism in Intestinal Inflammation.
    Bamidele AO; Svingen PA; Sagstetter MR; Sarmento OF; Gonzalez M; Braga Neto MB; Kugathasan S; Lomberk G; Urrutia RA; Faubion WA
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):55-71. PubMed ID: 30510991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
    DuPage M; Chopra G; Quiros J; Rosenthal WL; Morar MM; Holohan D; Zhang R; Turka L; Marson A; Bluestone JA
    Immunity; 2015 Feb; 42(2):227-238. PubMed ID: 25680271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).
    Sarmento OF; Svingen PA; Xiong Y; Sun Z; Bamidele AO; Mathison AJ; Smyrk TC; Nair AA; Gonzalez MM; Sagstetter MR; Baheti S; McGovern DP; Friton JJ; Papadakis KA; Gautam G; Xavier RJ; Urrutia RA; Faubion WA
    J Biol Chem; 2017 Jan; 292(2):706-722. PubMed ID: 27909059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M; Piccirillo CA
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic conversion of conventional T cells into regulatory T cells by CD28 signal deprivation.
    Mikami N; Kawakami R; Chen KY; Sugimoto A; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12258-12268. PubMed ID: 32414925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
    Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
    Front Immunol; 2018; 9():125. PubMed ID: 29456534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen-Rich Saline Ameliorates Allergic Rhinitis by Reversing the Imbalance of Th1/Th2 and Up-Regulation of CD4+CD25+Foxp3+Regulatory T Cells, Interleukin-10, and Membrane-Bound Transforming Growth Factor-β in Guinea Pigs.
    Xu F; Yu S; Qin M; Mao Y; Jin L; Che N; Liu S; Ge R
    Inflammation; 2018 Feb; 41(1):81-92. PubMed ID: 28894978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the PI3K-Akt-mTOR signaling pathway in T lymphocytes in patients with active tuberculosis.
    Zhang X; Huang T; Wu Y; Peng W; Xie H; Pan M; Zhou H; Cai B; Wu Y
    Int J Infect Dis; 2017 Jun; 59():110-117. PubMed ID: 28416440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis.
    Xiao XY; Li YT; Jiang X; Ji X; Lu X; Yang B; Wu LJ; Wang XH; Guo JB; Zhao LD; Fei YY; Yang HX; Zhang W; Zhang FC; Tang FL; Zhang JM; He W; Chen H; Zhang X
    J Autoimmun; 2020 Mar; 108():102404. PubMed ID: 31952907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells.
    Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ
    Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Default" generation of neonatal regulatory T cells.
    Wang G; Miyahara Y; Guo Z; Khattar M; Stepkowski SM; Chen W
    J Immunol; 2010 Jul; 185(1):71-8. PubMed ID: 20498359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adoptive transfer of CD4
    Wang J; Yang J; Yan Y; Zhu Z; Mu Y; Wang X; Zhang J; Liu L; Zhao F; Chi Y
    J Reprod Immunol; 2019 Feb; 131():30-35. PubMed ID: 30634133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.